Cumberland Pharmaceuticals
CPIX
45 hedge funds and large institutions have $29.4M invested in Cumberland Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 21 reducing their positions, and 20 closing their positions.
13% less capital invested
Capital invested by funds: $33.9M → $29.4M (-$4.42M)
25% less funds holding
Funds holding: 60 → 45 (-15)
57% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 21
75% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 20
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $5K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
+$1.66M |
| 2 |
BG
BlackRock Group
London,
United Kingdom
|
+$660K |
| 3 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
+$554K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$549K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$336K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$480K |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$454K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
-$386K |
| 4 |
Renaissance Technologies
New York
|
-$364K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$287K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CCM
51
Coldstream Capital Management
Bellevue,
Washington
| – | -$178K | -34,920 | Closed |
|
|
LMF
52
LMR Master Fund
Grand Cayman,
Cayman Islands
| – | -$119K | -23,416 | Closed |
|
|
CI
53
Cowen Inc
New York
| – | -$101K | -19,800 | Closed |
|
54
JP Morgan Chase
New York
| – | -$94K | -18,455 | Closed |
|
55
Jane Street
New York
| – | -$85K | -16,706 | Closed |
|
56
Barclays
London,
United Kingdom
| – | -$55K | -10,761 | Closed |
|
|
CS
57
Credit Suisse
Zurich,
Switzerland
| – | -$55K | -10,733 | Closed |
|
|
WIC
58
Woodmont Investment Counsel
Nashville,
Tennessee
| – | -$51K | -10,000 | Closed |
|
|
AIG
59
American International Group
New York
| – | -$41.8K | -8,182 | Closed |
|
60
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$36K | -7,013 | Closed |
|
|
TCIM
61
TIAA CREF Investment Management
New York
| – | -$16K | -3,114 | Closed |
|
|
BJ
62
BlackRock Japan
Tokyo,
Japan
| – | -$8K | -1,469 | Closed |
|
|
LTFS
63
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | -$1K | -200 | Closed |
|
|
SSG
64
Summit Securities Group
New York
| – | -$1K | -100 | Closed |
|
CPIX Hedge Fund Activity: Q3 2013 in Review
45 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q3 2013, worth a combined $29.4M — down 13% from $33.9M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of CPIX and 5 opened new positions — a net loss of 15 holders — while 21 trimmed existing stakes and 9 added.
The largest buyer was Ariel Investments, adding an estimated $1.66M. The largest seller was Morgan Stanley, cutting an estimated $480K.
- 45 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q3 2013, down from 60 in Q2 2013.
- Funds reported $29.4M of Cumberland Pharmaceuticals stock for Q3 2013, down 13% quarter-over-quarter.
- 5 funds opened new Cumberland Pharmaceuticals positions in Q3 2013 and 20 closed out, a net change of -15 holders.
- The largest Cumberland Pharmaceuticals buyer in Q3 2013 was Ariel Investments, an estimated $1.66M added.
- The largest Cumberland Pharmaceuticals seller in Q3 2013 was Morgan Stanley, an estimated $480K sold.
Based on aggregated 13F filings for Q3 2013.